RNA interference-mediated silencing of ppGalNAc-T1 and ppGalNAc-T2 inhibits invasion and increases chemosensitivity potentially by reducing terminal α2,3 sialylation and MMP14 expression in triple‑negative breast cancer cells

Qiu,Hao; Xu,Xu; Liu,Min; Wang,Zerong; Yuan,Yaqin; Liu,Chunliang; Xu,Lan; Wu,Shiliang

doi:10.3892/mmr.2017.6449

RNA interference-mediated silencing of ppGalNAc-T1 and ppGalNAc-T2 inhibits invasion and increases chemosensitivity potentially by reducing terminal α2,3 sialylation and MMP14 expression in triple‑negative breast cancer cells

Authors:
- Hao Qiu
- Xu Xu
- Min Liu
- Zerong Wang
- Yaqin Yuan
- Chunliang Liu
- Lan Xu
- Shiliang Wu
View Affiliations

Affiliations: Department of Biochemistry and Molecular Biology, School of Biology and Basic Medical Sciences, Soochow University, Suzhou, Jiangsu 215123, P.R. China, Department of Oncology, Nanjing University of Traditional Chinese Medicine Affiliated Suzhou Hospital of Traditional Chinese Medicine, Suzhou, Jiangsu 215128, P.R. China
Published online on: April 7, 2017 https://doi.org/10.3892/mmr.2017.6449
Pages: 3724-3734

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Glycopeptide-preferring polypeptide N-acetylgalactosamine transferase (ppGalNAc‑T) is a key enzyme that initiates the formation of the first GalNAc monosaccharide to polypeptides at Thr/Ser residues by O‑linked glycosylation. In order to investigate the effects of ppGalNAc‑T1 and ppGalNAc‑T2 on the initiation of O‑glycosylation, siRNA‑ppGalNAc‑T1 (si‑T1) and siRNA‑ppGalNAc‑T2 (si‑T2) were transfected into highly‑invasive estrogen receptor‑negative MDA‑MB‑231 cells to inhibit O‑glycosylation. Downregulation of ppGalNAc‑T1 demonstrated a significant reduction in the number of terminal α2,3 sialic acids, when compared to cells transfected with si‑T2 or si‑T1/T2. This downregulation led to a decrease in the invasion capabilities of the breast carcinoma cells, as well as enhanced chemosensitivity, which was the result antineoplastic drug effects. In addition, immunoprecipitation assays demonstrated that downregulation of ppGalNAc‑T1 led to a reduction in the number of terminal α2,3 sialic acids on O‑linked glycans of the matrix metalloproteinase‑14 (MMP14) glycoprotein. Furthermore, MMP14 and vascular endothelial growth factor were downregulated in the si‑T1 groups when compared with the si‑T2 and si‑T1/T2 groups. In conclusion, the results of the present study suggest that ppGalNAc‑T1 may serve a pivotal role in the initiation of O‑glycosylation, which may lead to a low density of α2,3 sialic acids on O‑linked glycans of MMP14 when downregulated. Glycosylation serves a significant role in regulating the sensitivity of MMP14 to self‑proteolysis, which ultimately decreases the invasion capabilities of breast cancer cells. The results of the present study may be useful in establishing the function of ppGalNAc‑T1 during breast cancer invasion and metastasis.

View Figures

View References

1	Davies EL: Breast cancer. Medicine. 44:42–46. 2016. View Article : Google Scholar
2	Lin NU, Claus E, Sohl J, Razzak AR, Arnaout A and Winer EP: Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: High incidence of central nervous system metastases. Cancer. 113:2638–2645. 2008. View Article : Google Scholar : PubMed/NCBI
3	Kim J, Villadsen R, Sørlie T, Fogh L, Grønlund SZ, Fridriksdottir AJ, Kuhn I, Rank F, Wielenga VT, Solvang H, et al: Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity. In: Proc Natl Acad Sci USA. 109. pp. 6124–6129. 2012; View Article : Google Scholar : PubMed/NCBI
4	Haddon L and Hugh J: MUC1-mediated motility in breast cancer: A review highlighting the role of the MUC1/ICAM-1/Src signaling triad. Clin Exp Metastasis. 32:393–403. 2015. View Article : Google Scholar : PubMed/NCBI
5	Saitoh O, Wang WC, Lotan R and Fukuda M: Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem. 267:5700–5711. 1992.PubMed/NCBI
6	Devi KS, Behera B, Mishra D and Maiti TK: Immune augmentation and Dalton's Lymphoma tumor inhibition by glucans/glycans isolated from the mycelia and fruit body of Pleurotus ostreatus. Int Immunopharmacol. 25:207–217. 2015. View Article : Google Scholar : PubMed/NCBI
7	Kalra AV and Campbell RB: Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours. Eur J Cancer. 45:164–173. 2009. View Article : Google Scholar : PubMed/NCBI
8	Ecker M, Mrsa V, Hagen I, Deutzmann R, Strahl S and Tanner W: O-mannosylation precedes and potentially controls the N-glycosylation of a yeast cell wall glycoprotein. EMBO Rep. 4:628–632. 2003. View Article : Google Scholar : PubMed/NCBI
9	Brockhausen I: Mucin-type O-glycans in human colon and breast cancer: Glycodynamics and functions. EMBO Rep. 7:599–604. 2006. View Article : Google Scholar : PubMed/NCBI
10	Varki A, Kannagi R and Toole BP: Glycosylation Changes in CancerEssentials of Glycobiology. 2nd. Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW and Etzler ME: Cold Spring Harbor Laboratory Press; Cold Spring Harbor, NY: 2009, View Article : Google Scholar
11	Nakada H: Map 2: Biosynthetic Pathways of O-Glycans. handbook of glycosyltransferases and related genes. 1667–1671. 2014. View Article : Google Scholar
12	Büll C, Stoel MA, den Brok MH and Adema GJ: Sialic acids sweeten a tumor's life. Cancer Res. 74:3199–3204. 2014. View Article : Google Scholar : PubMed/NCBI
13	Schultz MJ, Swindall AF and Bellis SL: Regulation of the metastatic cell phenotype by sialylated glycans. Cancer Metastasis Rev. 31:501–518. 2012. View Article : Google Scholar : PubMed/NCBI
14	Lin S, Kemmner W, Grigull S and Schlag PM: Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells. Exp Cell Res. 276:101–110. 2002. View Article : Google Scholar : PubMed/NCBI
15	Sproviero D, Julien S, Burford B, Taylor-Papadimitriou J and Burchell JM: Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer. J Biol Chem. 287:44490–44497. 2012. View Article : Google Scholar : PubMed/NCBI
16	Picco G, Julien S, Brockhausen I, Beatson R, Antonopoulos A, Haslam S, Mandel U, Dell A, Pinder S, Taylor-Papadimitriou J and Burchell J: Over-expression of ST3Gal-I promotes mammary tumorigenesis. Glycobiology. 20:1241–1250. 2010. View Article : Google Scholar : PubMed/NCBI
17	Tagashira M and Toma K: Effect of Peptide Glycosylation on the Conformation of the Peptide Backbone. Cheminform. 37:362006. View Article : Google Scholar
18	Wu YI, Munshi HG, Sen R, Snipas SJ, Salvesen GS, Fridman R and Stack MS: Glycosylation broadens the substrate profile of membrane type 1 matrix metalloproteinase. J Biol Chem. 279:8278–8289. 2004. View Article : Google Scholar : PubMed/NCBI
19	Remacle AG, Chekanov AV, Golubkov VS, Savinov AY, Rozanov DV and Strongin AY: O-glycosylation regulates autolysis of cellular membrane type-1 matrix metalloproteinase (MT1-MMP). J Biol Chem. 281:16897–16905. 2006. View Article : Google Scholar : PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
21	Gómez H, Rojas R, Patel D, Tabak LA, Lluch JM and Masgrau L: A computational and experimental study of O-glycosylation. Catalysis by human UDP-GalNAc polypeptide: GalNAc transferase-T2. Org Biomol Chem. 12:2645–2655. 2014. View Article : Google Scholar : PubMed/NCBI
22	Shaverdashvili K, Wong P, Ma J, Zhang K, Osman I and Bedogni B: MT1-MMP modulates melanoma cell dissemination and metastasis through activation of MMP2 and RAC1. Pigment Cell Melanoma Res. 27:287–296. 2014. View Article : Google Scholar : PubMed/NCBI
23	Loomans HA and Andl CD: Intertwining of Activin A and TGFβ Signaling: Dual roles in cancer progression and cancer cell invasion. Cancers (Basel). 7:70–91. 2014. View Article : Google Scholar : PubMed/NCBI
24	Hui P, Xu X, Xu L, Hui G, Wu S and Lan Q: Expression of MMP14 in invasive pituitary adenomas: Relationship to invasion and angiogenesis. Int J Clin Exp Pathol. 8:3556–3567. 2015.PubMed/NCBI
25	Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, et al: Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 10:5367–5374. 2004. View Article : Google Scholar : PubMed/NCBI
26	Guiu S, Michiels S, André F, Cortes J, Denkert C, Di Leo A, Hennessy BT, Sorlie T, Sotiriou C, Turner N, et al: Molecular subclasses of breast cancer: How do we define them? The IMPAKT 2012 Working Group Statement. Ann Oncol. 23:2997–3006. 2012. View Article : Google Scholar : PubMed/NCBI
27	Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P and Narod SA: Triplenegative breast cancer: Clinical features and patterns of recurrence. Clin Cancer Res. 13:4429–4434. 2007. View Article : Google Scholar : PubMed/NCBI
28	Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y and Pietenpol JA: Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 121:2750–2767. 2011. View Article : Google Scholar : PubMed/NCBI
29	Bilir B, Kucuk O and Moreno CS: Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells. J Transl Med. 11:2802013. View Article : Google Scholar : PubMed/NCBI
30	Brooks M: Breast cancer screening and biomarkers. Methods Mol Biol. 472:307–321. 2009. View Article : Google Scholar : PubMed/NCBI
31	Paszek MJ, DuFort CC, Rossier O, Bainer R, Mouw JK, Godula K, Hudak JE, Lakins JN, Wijekoon AC, Cassereau L, et al: The cancer glycocalyx mechanically primes integrin-mediated growth and survival. Nature. 511:319–325. 2014. View Article : Google Scholar : PubMed/NCBI
32	Zhang L, Tian T, Kelly G and Hagen T: UDP-N-Acetyl-Alpha-D Galactosamine: Polypeptide N-Acetylgalactosaminyltransferases (ppGalNAc-Ts). Handbook of Glycosyltransferases and Related Genes. 495–505. 2014. View Article : Google Scholar
33	Ten Hagen KG, Fritz TA and Tabak LA: All in the family: The UDP-GalNAc: Polypeptide N-acetylgalactosaminyltransferases. Glycobiology. 13:1R–16R. 2003. View Article : Google Scholar : PubMed/NCBI
34	Tian E and Ten Hagen KG: Expression of the UDP-GalNAc: Polypeptide N-acetylgalactosaminyltransferase family is spatially and temporally regulated during Drosophila development. Glycobiology. 16:83–95. 2006. View Article : Google Scholar : PubMed/NCBI
35	Perrine CL, Ganguli A, Wu P, Bertozzi CR, Fritz TA, Raman J, Tabak LA and Gerken TA: Glycopeptide-preferring polypeptide GalNAc transferase 10 (ppGalNAc T10), involved in mucin-type O-glycosylation, has a unique GalNAc-O-Ser/Thr-binding site in its catalytic domain not found in ppGalNAc T1 or T2. J Biol Chem. 284:20387–20397. 2009. View Article : Google Scholar : PubMed/NCBI
36	Bennett EP, Hassan H, Hollingsworth MA and Clausen H: A novel human UDP-N-acetyl-D-galactosamine: Polypeptide N-acetylgalactosaminyltransferase, GalNAc-T7, with specificity for partial GalNAc-glycosylated acceptor substrates. FEBS Lett. 460:226–230. 1999. View Article : Google Scholar : PubMed/NCBI
37	Cheng L, Tachibana K, Zhang Y, Guo JM, Kahori Tachibana K, Kameyama A, Wang H, Hiruma T, Iwasaki H, Togayachi A, et al: Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T10. FEBS Lett. 531:115–121. 2002. View Article : Google Scholar : PubMed/NCBI
38	Brooks SA, Carter TM, Bennett EP, Clausen H and Mandel U: Immunolocalisation of members of the polypeptide N-acetylgalactosaminyl transferase (ppGalNAc-T) family is consistent with biologically relevant altered cell surface glycosylation in breast cancer. Acta Histochem. 109:273–284. 2007. View Article : Google Scholar : PubMed/NCBI
39	Ding MX, Wang HF, Wang JS, Zhan H, Zuo YG, Yang DL, Liu JY, Wang W, Ke CX and Yan RP: ppGalNAc T1 as a potential novel marker for human bladder cancer. Asian Pac J Cancer Prev. 13:5653–5657. 2012. View Article : Google Scholar : PubMed/NCBI
40	Hua D, Shen L, Xu L, Jiang Z, Zhou Y, Yue A, Zou S, Cheng Z and Wu S: Polypeptide N-acetylgalactosaminyltransferase 2 regulates cellular metastasis-associated behavior in gastric cancer. Int J Mol Med. 30:1267–1274. 2012.PubMed/NCBI
41	Fukuda M: Beta-1,3-Galactosyl-O-Glycosyl-Glycoprotein Beta-1,6-N-Acetylglucosaminyltransferase 1 (GCNT1) (C2GnT-L) and Beta-1,3-Galactosyl-O-Glycosyl-Glycoprotein Beta-1,6-N-Acetylglucosaminyltransferase 3 (GCNT4) (C2GnT-T). Handbook Of Glycosyltransferases and Related genes. 355–366. 2014.
42	Skrincosky D, Kain R, El-Battari A, Exner M, Kerjaschki D and Fukuda M: Altered Golgi localization of core 2 beta-1,6-N-acetylglucosaminyltransferase leads to decreased synthesis of branched O-glycans. J Biol Chem. 272:22695–22702. 1997. View Article : Google Scholar : PubMed/NCBI
43	Pearce OM and Läubli H: Sialic acids in cancer biology and immunity. Glycobiology. 26:111–128. 2016. View Article : Google Scholar : PubMed/NCBI
44	Woskowicz AM, Weaver SA, Shitomi Y, Ito N and Itoh Y: MT-LOOP-dependent localization of membrane type I matrix metalloproteinase (MT1-MMP) to the cell adhesion complexes promotes cancer cell invasion. J Biol Chem. 288:35126–35137. 2013. View Article : Google Scholar : PubMed/NCBI
45	Têtu B, Brisson J, Wang CS, Lapointe H, Beaudry G, Blanchette C and Trudel D: The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis. Breast Cancer Res. 8:R282006. View Article : Google Scholar : PubMed/NCBI
46	Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 370:61–65. 1994. View Article : Google Scholar : PubMed/NCBI
47	Deng YP, Li W and Li YL, Xu H, Liang SS, Zhang LH and Li YL: MT1-MMP up-regulates VEGF expression in human breast carcinoma MCF-7 cells and induces tumor angiogenesis. Zhonghua Zhong Liu Za Zhi. 31:727–731. 2009.(In Chinese). PubMed/NCBI